The NAC Supplement for Women Worth Knowing About
- Kirsten

- 11 hours ago
- 4 min read

N-acetylcysteine has been used in medicine for decades. Now it is showing up in conversations about endometriosis, PMOS and inflammation and for good reason
If NAC has started appearing on your radar, you are not alone. NAC has quietly moved from hospital medicine cabinets into the supplement aisle, and women with conditions like endometriosis and polyendocrine metabolic ovarian syndrome (PMOS) are increasingly asking whether it belongs in their routine. The research is still developing, but what exists is genuinely interesting.
What NAC Actually Is
NAC is a form of the amino acid cysteine, and its main job in the body is to help produce glutathione, one of the most important antioxidants the body makes naturally. Glutathione is involved in managing inflammation and protecting cells from damage. The body produces it continuously, but stress, poor sleep, certain health conditions and ageing can all deplete it.
The reason NAC matters here is that taking glutathione directly as a supplement is largely ineffective because the body cannot absorb it well. NAC is absorbed readily and gives the body the raw material it needs to make more of its own. That makes it a more practical route to raising glutathione levels, which is why researchers have been exploring its potential across a range of inflammatory conditions, several of which affect women disproportionately.
NAC and Endometriosis
Endometriosis is a chronic inflammatory condition affecting around 1.5 million women in the UK. Inflammation is at its core, which is exactly why NAC has attracted attention as a potential supportive option.
Italian researchers have conducted the most significant work in this area. An observational study of 92 women with confirmed ovarian endometriosis found that those taking NAC saw a reduction in cyst size over three months, while cysts in the untreated group grew over the same period. A follow-up study of 120 women published in 2023 reported meaningful reductions in pelvic pain, painful periods and pain during sex, alongside reductions in cyst size and in a key inflammation marker called Ca-125. NSAID use also fell among participants.
These are promising findings. They come from observational studies rather than large-scale clinical trials, so NAC cannot yet be described as a proven treatment for endometriosis. What the research does suggest is that it may be a useful, low-risk addition to a broader management plan, and that is a conversation worth having with a gynaecologist.
NAC and PMOS
PMOS, formally known as PCOS, was officially renamed in May 2026 following a global medical consensus published in The Lancet. The new name, polyendocrine metabolic ovarian syndrome, better reflects what the condition actually involves: a complex hormonal disorder affecting metabolism, reproductive health, skin, mental health and more. It affects one in eight women.
Oxidative stress, which is essentially an imbalance between damaging molecules and the body's ability to neutralise them, is a well-recognised feature of PMOS. It appears to worsen insulin resistance, which is one of the condition's central drivers. Several clinical trials have found that NAC supplementation can improve insulin sensitivity and reduce inflammation markers in women with PMOS, and some studies have shown improvements in ovulation rates compared to placebo. A 2023 review drawing on 11 clinical trials and nearly 900 women found consistent improvements in metabolic markers with NAC use.
The evidence here is stronger than for endometriosis because it includes randomised controlled trial data. NAC is not a replacement for medical treatment or prescribed medication, but for women managing PMOS, it is among the more evidence-backed supplements currently being discussed.
Which Women Might Benefit
The thread connecting both conditions is inflammation and oxidative stress. Women living with endometriosis or PMOS, particularly those looking for non-hormonal, low-risk options to support their existing care, are the women most likely to find the current research relevant.
There is also growing interest in NAC's potential role in perimenopause and thyroid health, areas where inflammation and oxidative stress are increasingly recognised as significant factors. The evidence in those areas is earlier stage, but the biological rationale is consistent.
Before Taking NAC
NAC is widely available in the UK as an over-the-counter supplement, typically at 600mg. The studies referenced in this article used 600mg taken three days per week or daily over three months. It has a well-established safety profile and no significant adverse effects were reported in the clinical trials mentioned here.
Women who are pregnant, breastfeeding or taking anticoagulant medication should speak to a doctor before starting it. As with all supplements, quality varies between brands and supplements are not regulated to the same standard as medicines.
NAC is not a fix, and the research is not yet at the level where clinicians will prescribe it routinely. But the evidence is solid enough to make it one of the more credible supplements in the women's health conversation right now, and one that is worth raising with a doctor.
References
Anastasi E, et al. Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes. International Journal of Environmental Research and Public Health.2023;20(6):4686.
Porpora MG, et al. A Promise in the Treatment of Endometriosis: An Observational Cohort Study on Ovarian Endometrioma Reduction by N-Acetylcysteine. Evidence-Based Complementary and Alternative Medicine.2013;2013:240702.
Liu J, et al. The effects of N-acetylcysteine supplement on metabolic parameters in women with polycystic ovary syndrome: a systematic review and meta-analysis. Frontiers in Nutrition. 2023;10:1209614.
Yang X, et al. A review of antioxidant N-acetylcysteine in addressing polycystic ovary syndrome. Gynecological Endocrinology. 2024;40(1).
Cheraghi E, et al. The effects of N-acetylcysteine on ovulation and sex hormones profile in women with polycystic ovary syndrome: a systematic review and meta-analysis. British Journal of Nutrition. 2023.
Zhang Y, et al. N-acetylcysteine supplementation improves endocrine-metabolism profiles and ovulation induction efficacy in polycystic ovary syndrome. Journal of Ovarian Research. 2024.
Vina I, et al. N-acetylcysteine and women's health: hormonal and metabolic pathways. Nutrients. 2025;17(2):284.
Teede HJ, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. Published online 12 May 2026.
Editorial Note
This article is for informational purposes only and is not a substitute for professional medical advice. If you have concerns about your health, always speak to a qualified healthcare professional first, before making changes to your diet, routine or treatment plan.


Comments